We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-3.25%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.01B
AUM Growth
+$262M
Cap. Flow
-$162M
Cap. Flow %
-2.7%
Top 10 Hldgs %
51.52%
Holding
592
New
224
Increased
125
Reduced
42
Closed
159

Top Buys

Rank Stock Value
1
WAY
Waystar Holding Corp
WAY
+$107M
2
GILD icon
Gilead Sciences
GILD
+$99.5M
3
CVS icon
CVS Health
CVS
+$61M
4
BAX icon
Baxter International
BAX
+$57.9M
5
CGEM icon
Cullinan Oncology
CGEM
+$45.6M

Top Sells

Rank Stock Value
1
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$136M
2
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$80.7M
3
SWTX
SpringWorks Therapeutics
SWTX
+$63.2M
4
OSCR icon
Oscar Health
OSCR
+$44.4M
5
VKTX icon
Viking Therapeutics
VKTX
+$38M

Sector Composition

Rank Sector Weight
1 Healthcare 83.29%
2 Industrials 0.69%
3 Technology 0.57%
4 Financials 0.44%
5 Consumer Discretionary 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRCT icon
251
Procept Biorobotics
PRCT
$1.01B
$515K 0.01%
+8,426
New +$501K
THC icon
252
Tenet Healthcare
THC
$21B
$511K 0.01%
+3,840
New +$462K
AN icon
253
AutoNation
AN
$7.1B
$511K 0.01%
+3,204
New +$523K
ARWR icon
254
Arrowhead Research
ARWR
$12B
$506K 0.01%
+19,461
New +$478K
AME icon
255
Ametek
AME
$55.7B
$502K 0.01%
+3,011
New +$520K
CRBG icon
256
Corebridge Financial
CRBG
$14.3B
$500K 0.01%
+17,168
New +$494K
HAE icon
257
Haemonetics
HAE
$3.63B
$499K 0.01%
+6,036
New +$531K
PCRX icon
258
Pacira BioSciences
PCRX
$1.04B
$488K 0.01%
+17,062
New +$486K
CHWY icon
259
Chewy
CHWY
$8.93B
$486K 0.01%
17,835
-15,185
-46% -$289K
NEO icon
260
NeoGenomics
NEO
$1.71B
$481K 0.01%
+34,670
New +$492K
FMC icon
261
FMC
FMC
$1.39B
$474K 0.01%
+8,233
New +$492K
SRI icon
262
Stoneridge
SRI
$210M
$472K 0.01%
+29,592
New +$474K
HR icon
263
Healthcare Realty
HR
$7.46B
$471K 0.01%
+28,566
New +$437K
DBX icon
264
Dropbox
DBX
$7.13B
$468K 0.01%
+20,820
New +$476K
EXEL icon
265
Exelixis
EXEL
$14B
$468K 0.01%
20,816
+12,036
+137% +$267K
WST icon
266
West Pharmaceutical
WST
$23.3B
$464K 0.01%
+1,409
New +$498K
LOPE icon
267
Grand Canyon Education
LOPE
$3.84B
$463K 0.01%
+3,308
New +$456K
LYFT icon
268
Lyft
LYFT
$5.73B
$458K 0.01%
+32,516
New +$528K
QLYS icon
269
Qualys
QLYS
$4.75B
$458K 0.01%
+3,214
New +$489K
PGNY icon
270
Progyny
PGNY
$2.47B
$452K 0.01%
15,809
+9,101
+136% +$274K
CHD icon
271
Church & Dwight Co
CHD
$23.4B
$449K 0.01%
+4,331
New +$458K
ADPT icon
272
Adaptive Biotechnologies
ADPT
$3.61B
$445K 0.01%
122,841
+57,554
+88% +$183K
MCY icon
273
Mercury Insurance
MCY
$6.01B
$445K 0.01%
8,367
+2,102
+34% +$114K
EGP icon
274
EastGroup Properties
EGP
$11.3B
$444K 0.01%
+2,610
New +$431K
HNST icon
275
The Honest Company
HNST
$423M
$439K 0.01%
150,190
+41,222
+38% +$123K
9 10
11
12 13

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q2 2024 Portfolio in Review

As of Q2 2024, Deerfield Management held 592 positions worth $6.01B, up 4.6% from $5.75B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q2 2024 filing shows 224 new, 125 increased, 42 reduced and 159 closed positions. Its largest new stake was Waystar Holding Corp: 4,952,004 shares worth $106M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $136M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 89% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q2 2024 buy was Waystar Holding Corp: 4,952,004 shares worth $106M.
  • Deerfield Management added most to Baxter International in Q2 2024, an estimated $57.9M increase.
  • Deerfield Management's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $44.4M.
  • Deerfield Management fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $136M.
  • Deerfield Management's ten largest holdings make up 52% of its $6.01B portfolio in Q2 2024.
  • Deerfield Management opened 224 new positions and closed 159 in Q2 2024.
  • Deerfield Management's portfolio value rose 4.6% quarter-over-quarter to $6.01B.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.